AR049929A1 - Metodos y composiciones para el tratamiento de afecciones oftalmicas con derivados de retinilo - Google Patents
Metodos y composiciones para el tratamiento de afecciones oftalmicas con derivados de retiniloInfo
- Publication number
- AR049929A1 AR049929A1 ARP050102545A ARP050102545A AR049929A1 AR 049929 A1 AR049929 A1 AR 049929A1 AR P050102545 A ARP050102545 A AR P050102545A AR P050102545 A ARP050102545 A AR P050102545A AR 049929 A1 AR049929 A1 AR 049929A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- methods
- derivatives
- ophthaltic
- affections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/16—Ophthalmology
- G01N2800/164—Retinal disorders, e.g. retinopathy
Abstract
Los compuestos que producen ceguera nocturna reversible pueden usarse para tratar condiciones oftálmicas asociadas con la sobreproduccion de productos de desecho que se acumulan durante el curso del ciclo visual. Se decriben métodos y composiciones que usan tales compuestos y sus derivados para tratar, entre otras, las degeneraciones y distrofias maculares o para aliviar síntomas asociados con tales condiciones oftálmicas. Los compuestos y sus derivados pueden usarse como agentes de una terapia unica o en combinacion con otros agentes o terapias.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58229304P | 2004-06-23 | 2004-06-23 | |
US62969504P | 2004-11-19 | 2004-11-19 | |
US66090405P | 2005-03-11 | 2005-03-11 | |
US67240505P | 2005-04-18 | 2005-04-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR049929A1 true AR049929A1 (es) | 2006-09-13 |
Family
ID=34981643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050102545A AR049929A1 (es) | 2004-06-23 | 2005-06-21 | Metodos y composiciones para el tratamiento de afecciones oftalmicas con derivados de retinilo |
Country Status (27)
Country | Link |
---|---|
US (3) | US8314152B2 (es) |
EP (3) | EP1768657B1 (es) |
JP (1) | JP4855396B2 (es) |
KR (1) | KR100862930B1 (es) |
AR (1) | AR049929A1 (es) |
AT (1) | ATE404188T1 (es) |
AU (1) | AU2005262558B8 (es) |
BR (1) | BRPI0512569A (es) |
CA (1) | CA2569691C (es) |
CY (1) | CY1110435T1 (es) |
DE (1) | DE602005008970D1 (es) |
DK (1) | DK1768657T3 (es) |
EA (1) | EA011864B1 (es) |
ES (1) | ES2313368T3 (es) |
GE (1) | GEP20084520B (es) |
HK (1) | HK1107671A1 (es) |
IL (1) | IL179872A (es) |
LV (1) | LV13564B (es) |
MX (1) | MXPA06014978A (es) |
NO (1) | NO20070408L (es) |
NZ (1) | NZ551955A (es) |
PL (1) | PL1768657T3 (es) |
PT (1) | PT1768657E (es) |
SG (1) | SG140607A1 (es) |
SI (1) | SI1768657T1 (es) |
TW (1) | TWI396532B (es) |
WO (1) | WO2006007314A1 (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2004222279B2 (en) | 2003-03-14 | 2010-01-21 | University Of Washington | Retinoid replacements and opsin agonists and methods for the use thereof |
WO2005079774A2 (en) | 2004-02-17 | 2005-09-01 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
US7566808B2 (en) | 2004-02-17 | 2009-07-28 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
JP2007525496A (ja) * | 2004-02-17 | 2007-09-06 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 黄班変性症を含む眼科疾患の管理 |
BRPI0511396B1 (pt) | 2004-06-18 | 2021-07-27 | University Of Washington | Uso de 9-cis-retinil éster e uso de um derivado de retinal sintético |
PL1768657T3 (pl) | 2004-06-23 | 2009-01-30 | Revision Therapeutics Inc | Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych |
US20060089411A1 (en) * | 2004-08-07 | 2006-04-27 | Gierhart Dennis L | Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin |
JP2008515778A (ja) * | 2004-08-18 | 2008-05-15 | シリオン セラピューティクス, インコーポレイテッド | 眼の状態を13−シス−レチニル誘導体で処置するための組み合わせ方法、組成物および治療 |
CA2580363A1 (en) * | 2004-10-28 | 2006-05-11 | Idexx Laboratories, Inc. | Compositions for controlled delivery of pharmaceutically active compounds |
KR20070091283A (ko) * | 2004-11-04 | 2007-09-10 | 시리온 테라퓨틱스, 인크. | 레티놀-레티놀 결합단백질(rbp)-트랜스타이레틴(ttr) 복합체 형성의조절 인자 |
NZ561148A (en) * | 2004-12-08 | 2008-12-24 | Sirion Therapeutics Inc | Methods, assays and compositions for treating retinol-related diseases |
UA81382C2 (en) * | 2005-07-11 | 2007-12-25 | Composition for treating retinol-related diseases by modulation of retinol binding | |
US7754679B2 (en) * | 2005-11-16 | 2010-07-13 | Idexx Laboratories, Inc. | Pharmaceutical compositions for the administration of aptamers |
US8114440B2 (en) * | 2005-11-16 | 2012-02-14 | Idexx Laboratories Inc. | Pharmaceutical compositions for the administration of aptamers |
CN101500594A (zh) * | 2006-06-22 | 2009-08-05 | 西来昂诊疗公司 | 通过调节巨蛋白活性治疗眼病的方法和组合物 |
WO2008013984A2 (en) * | 2006-07-27 | 2008-01-31 | University Of Florida Research Foundation, Inc. | Compositions and methods for treating or preventing ophthalmic disease |
WO2008013983A2 (en) * | 2006-07-27 | 2008-01-31 | University Of Florida Research Foundation, Inc. | Opsin stabilizing compounds and methods of use |
CA2657164A1 (en) * | 2006-07-27 | 2008-01-31 | University Of Florida Research Foundation, Inc. | Compositions and methods for treating or preventing ophthalmic light toxicity |
US8828960B2 (en) * | 2007-07-17 | 2014-09-09 | Idexx Laboratories, Inc. | Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds |
RU2565448C2 (ru) | 2008-02-11 | 2015-10-20 | Юниверсити Оф Вашингтон | Способы лечения и предупреждения обусловленной возрастом дисфункции сетчатки |
US8460635B2 (en) * | 2008-03-12 | 2013-06-11 | Albert Einstein College Of Medicine Of Yeshiva University | Fenretinide derivatives and uses thereof as therapeutic, diagnostic and imaging agents |
WO2010008995A2 (en) * | 2008-07-14 | 2010-01-21 | Otonomy, Inc. | Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
ES2549916T3 (es) * | 2009-05-04 | 2015-11-03 | Acucela, Inc. | Composiciones para usar en el tratamiento de glaucoma o hipertensión ocular |
IN2012DN00352A (es) | 2009-06-16 | 2015-08-21 | Bikam Pharmaceuticals Inc | |
MX2012003220A (es) | 2009-09-15 | 2012-08-03 | Quadra Logic Tech Inc | Formulaciones farmaceuticas que comprenden 9-cis-retinil esteres en un vehiculo de lipido. |
AU2010328186B2 (en) | 2009-12-08 | 2014-12-18 | Case Western Reserve University | Compounds and methods of treating ocular disorders |
RU2622763C2 (ru) | 2010-04-19 | 2017-06-19 | Новелион Терапьютикс Инк. | Лечебная схема и способы лечения или уменьшения нарушений зрения, связанных с дефицитом эндогенных ретиноидов |
AU2012346214B2 (en) | 2011-11-30 | 2017-09-14 | Bikam Pharmaceuticals, Inc. | Opsin-binding ligands, compositions and methods of use |
KR102060210B1 (ko) * | 2012-02-10 | 2019-12-27 | 타이완 리포좀 캄파니 리미티드 | 안용 스테로이드의 합병증을 감소시키기 위한 약학 조성물 |
WO2013134867A1 (en) | 2012-03-01 | 2013-09-19 | Qlt Inc. | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
US9011845B2 (en) | 2012-06-26 | 2015-04-21 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Methods for treatment of inflammatory and infectious viral diseases |
US8877183B2 (en) | 2012-06-26 | 2014-11-04 | National Institutes Of Health (Nih) | Methods for treatment of ocular diseases |
US9265458B2 (en) | 2012-12-04 | 2016-02-23 | Sync-Think, Inc. | Application of smooth pursuit cognitive testing paradigms to clinical drug development |
US9380976B2 (en) | 2013-03-11 | 2016-07-05 | Sync-Think, Inc. | Optical neuroinformatics |
US10092393B2 (en) | 2013-03-14 | 2018-10-09 | Allotex, Inc. | Corneal implant systems and methods |
US10471118B2 (en) * | 2014-05-30 | 2019-11-12 | Case Western Reserve University | Retinylamine derivitives for treatment of ocular disorders |
WO2016063933A1 (ja) | 2014-10-24 | 2016-04-28 | 武田薬品工業株式会社 | 複素環化合物 |
JP2017538728A (ja) * | 2014-12-19 | 2017-12-28 | ケミン、インダストリーズ、インコーポレーテッドKemin Industries, Inc. | イオントフォレシスを用いた生物活性分子の眼内送達 |
US10449090B2 (en) | 2015-07-31 | 2019-10-22 | Allotex, Inc. | Corneal implant systems and methods |
ES2949696T3 (es) * | 2016-02-15 | 2023-10-02 | Kemin Ind Inc | Liposomas cargados positivamente como portadores de moléculas lipofílicas |
US11395853B2 (en) * | 2016-06-23 | 2022-07-26 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Biomimetic drug delivery of an immunomodulatory agent for the treatment of ocular conditions |
CN110213987A (zh) | 2016-12-05 | 2019-09-06 | 杰克逊实验室 | 视网膜和视神经中的脂肪滴作为人类的神经变性和青光眼的诊断标志物 |
EP3650045A4 (en) * | 2017-07-04 | 2021-07-07 | Daiichi Sankyo Company, Limited | MEDICINAL PRODUCTS FOR RETINA DEGENERATIVE DISEASE ASSOCIATED WITH PHOTORECEPTOR DEGENERATION |
BR112021022270A2 (pt) * | 2019-05-06 | 2022-01-11 | Univ California | Materiais e métodos para tratar degeneração macular relacionada à idade |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4190594A (en) | 1975-11-03 | 1980-02-26 | Johnson & Johnson | Retinoic acid derivatives |
US4323581A (en) | 1978-07-31 | 1982-04-06 | Johnson & Johnson | Method of treating carcinogenesis |
US4665098A (en) | 1985-03-28 | 1987-05-12 | Mcneilab, Inc. | Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability |
US4874795A (en) | 1985-04-02 | 1989-10-17 | Yesair David W | Composition for delivery of orally administered drugs and other substances |
US4673044A (en) * | 1985-08-02 | 1987-06-16 | Eastman Christensen Co. | Earth boring bit for soft to hard formations |
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US4682663A (en) * | 1986-02-18 | 1987-07-28 | Reed Tool Company | Mounting means for cutting elements in drag type rotary drill bit |
US4743400A (en) | 1986-09-22 | 1988-05-10 | Mcneilab, Inc. | Process for preparing retinoyl chlorides |
AU6141490A (en) | 1989-07-28 | 1991-03-11 | Sloan-Kettering Institute For Cancer Research | Growth factors containing vitamin a or other retinoids and uses thereof |
US5814612A (en) | 1991-04-09 | 1998-09-29 | Sloan-Kettering Institute For Cancer Research | Retinol derivatives and uses thereof |
US6992108B1 (en) | 1991-12-18 | 2006-01-31 | The Salk Institute For Biological Studies | Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
US6050354A (en) * | 1992-01-31 | 2000-04-18 | Baker Hughes Incorporated | Rolling cutter bit with shear cutting gage |
US5314909A (en) | 1993-03-17 | 1994-05-24 | Merck & Co., Inc. | Use of non-steroidal antiiflammatory agents in macular degeneration |
US5399757A (en) | 1993-07-20 | 1995-03-21 | Ortho Pharmaceutical Corporation | Process for the preparation of N-(4-hydroxyphenyl)-retinamide |
US5824685A (en) | 1995-02-01 | 1998-10-20 | The Johns Hopkins University School Of Medicine | Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
US5596011A (en) | 1995-04-06 | 1997-01-21 | Repine; Karen M. | Method for the treatment of macular degeneration |
US5702357A (en) * | 1995-06-07 | 1997-12-30 | Cobe Laboratories, Inc. | Extracorporeal blood processing methods and apparatus |
US5706906A (en) * | 1996-02-15 | 1998-01-13 | Baker Hughes Incorporated | Superabrasive cutting element with enhanced durability and increased wear life, and apparatus so equipped |
US5758733A (en) * | 1996-04-17 | 1998-06-02 | Baker Hughes Incorporated | Earth-boring bit with super-hard cutting elements |
US5846220A (en) | 1996-04-30 | 1998-12-08 | Medtronic, Inc. | Therapeutic method for treatment of Alzheimer's disease |
US6034211A (en) | 1996-06-03 | 2000-03-07 | Kelly; Jeffery W. | β-sheet nucleating peptidomimetics |
GB9621217D0 (en) * | 1996-10-11 | 1996-11-27 | Camco Drilling Group Ltd | Improvements in or relating to preform cutting elements for rotary drill bits |
AU5727798A (en) | 1996-12-23 | 1998-07-17 | Texas A & M University, The | Anti-amyloidogenic agents |
US5955305A (en) | 1997-04-28 | 1999-09-21 | Incyte Pharmaceuticals, Inc. | Human retinoid binding protein |
US5776915A (en) | 1997-08-12 | 1998-07-07 | Clarion Pharmaceuticals Inc. | Phosphocholines of retinoids |
CZ300929B6 (cs) | 1997-08-15 | 2009-09-16 | Duke University | Sloucenina pro použití pri lécení nebo prevenci estrogenem stimulované rakoviny |
AU3980499A (en) | 1998-05-11 | 1999-11-29 | Endowment for Research in Human Biology, Inc., The | Use of neomycin for treating angiogenesis-related diseases |
US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
US7229961B2 (en) | 1999-08-24 | 2007-06-12 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into ocular tissues |
EP1216221A2 (en) | 1999-09-14 | 2002-06-26 | Ligand Pharmaceuticals Incorporated | Rxr modulators with improved pharmacologic profile |
WO2001038344A2 (en) | 1999-11-23 | 2001-05-31 | Gerhart Graupner | Modulation of signal transduction |
US20020031539A1 (en) | 2000-08-30 | 2002-03-14 | The Brigham And Women's Hospital, Inc. | Oxidized forms of retinoic acid as ligands for peroxisome proliferator activated receptor gamma |
US20020143062A1 (en) | 2000-10-17 | 2002-10-03 | Board Of Regents, The University Of Texas System | Method to incorporate N-(4-hydroxyphenyl) retinamide in liposomes |
US6408958B1 (en) * | 2000-10-23 | 2002-06-25 | Baker Hughes Incorporated | Superabrasive cutting assemblies including cutters of varying orientations and drill bits so equipped |
EP1349545B1 (en) | 2000-12-05 | 2008-11-19 | Childrens Hospital Of Los Angeles | Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same |
US20030032078A1 (en) | 2001-01-23 | 2003-02-13 | Board Of Regents, The University Of Texas System | Methods and compositions for the treatment of macular and retinal degenerations |
JP2004526807A (ja) | 2001-05-29 | 2004-09-02 | ケビジェン カンパニー リミテッド | 新規のレチノイド誘導体及びその製造方法並びにその化合物を含有する抗癌剤組成物 |
CA2450562A1 (en) | 2001-06-22 | 2003-01-03 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
WO2003003987A2 (en) | 2001-07-06 | 2003-01-16 | The Ohio State University Research Foundation | Solid phase synthesis of arylretinamides |
WO2003007944A1 (en) | 2001-07-20 | 2003-01-30 | Qlt, Inc. | Treatment of macular edema with photodynamic therapy |
US20030229062A1 (en) | 2001-12-07 | 2003-12-11 | The Regents Of The University Of California | Treatments for age-related macular degeneration (AMD) |
US20040014131A1 (en) | 2002-07-09 | 2004-01-22 | Pfizer Inc. | Assay methods |
WO2004041160A2 (en) | 2002-10-30 | 2004-05-21 | University Of Kentucky Research Foundation | Methods and animal model for analyzing age-related macular degeneration |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
AU2003294757A1 (en) | 2002-11-29 | 2004-06-23 | Axxima Pharmaceuticals Ag | Formulations useful against hepatitis c virus infections |
SI21392A (sl) | 2002-12-24 | 2004-06-30 | Vinko Kunc | Postopek za avtomatsko nastavitev ojačenja izpraševalnikovega sprejemnika v brezkontaktnem identifikacijskem sistemu |
DK1594544T3 (en) | 2003-01-31 | 2016-07-25 | Los Angeles Childrens Hospital | ORAL COMPOSITIONS OF FENRETINIDE WHICH HAVE INCREASED BIOTAILABILITY AND PROCEDURES FOR USING IT |
FI20030426A (fi) | 2003-03-24 | 2004-09-25 | Tomi Jaervinen | Syklodekstriinikompleksit |
US7178609B2 (en) * | 2003-08-19 | 2007-02-20 | Baker Hughes Incorporated | Window mill and drill bit |
CA2548285A1 (en) | 2003-12-11 | 2005-06-30 | Beth Israel Deaconess Medical Center, Inc. | Rbp4 in insulin sensitivity/resistance, diabetes, and obesity |
WO2005077176A1 (en) | 2004-02-11 | 2005-08-25 | The Trustees Of Columbia University In The City Of New York | Anthocyanin compounds and methods of use thereof |
WO2005079774A2 (en) * | 2004-02-17 | 2005-09-01 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
US7566808B2 (en) | 2004-02-17 | 2009-07-28 | President And Fellows Of Harvard College | Management of ophthalmologic disorders, including macular degeneration |
EP1727529B1 (en) | 2004-03-17 | 2016-03-02 | Lars Michael Larsen | Prevention of retinopathy by inhibition of the visual cycle |
BRPI0511396B1 (pt) | 2004-06-18 | 2021-07-27 | University Of Washington | Uso de 9-cis-retinil éster e uso de um derivado de retinal sintético |
PL1768657T3 (pl) | 2004-06-23 | 2009-01-30 | Revision Therapeutics Inc | Sposoby i kompozycje do leczenia stanów ocznych za pomocą pochodnych retinylowych |
US7286860B2 (en) | 2004-07-23 | 2007-10-23 | Dyna Llc | Systems and methods for a comfortable wireless communication device |
JP2008515778A (ja) | 2004-08-18 | 2008-05-15 | シリオン セラピューティクス, インコーポレイテッド | 眼の状態を13−シス−レチニル誘導体で処置するための組み合わせ方法、組成物および治療 |
KR20070091283A (ko) | 2004-11-04 | 2007-09-10 | 시리온 테라퓨틱스, 인크. | 레티놀-레티놀 결합단백질(rbp)-트랜스타이레틴(ttr) 복합체 형성의조절 인자 |
NZ561148A (en) | 2004-12-08 | 2008-12-24 | Sirion Therapeutics Inc | Methods, assays and compositions for treating retinol-related diseases |
UA81382C2 (en) | 2005-07-11 | 2007-12-25 | Composition for treating retinol-related diseases by modulation of retinol binding |
-
2005
- 2005-06-06 PL PL05758777T patent/PL1768657T3/pl unknown
- 2005-06-06 DK DK05758777T patent/DK1768657T3/da active
- 2005-06-06 EP EP05758777A patent/EP1768657B1/en not_active Not-in-force
- 2005-06-06 EA EA200700109A patent/EA011864B1/ru not_active IP Right Cessation
- 2005-06-06 GE GEAP20059816A patent/GEP20084520B/en unknown
- 2005-06-06 PT PT05758777T patent/PT1768657E/pt unknown
- 2005-06-06 MX MXPA06014978A patent/MXPA06014978A/es active IP Right Grant
- 2005-06-06 WO PCT/US2005/020080 patent/WO2006007314A1/en active Application Filing
- 2005-06-06 AT AT05758777T patent/ATE404188T1/de active
- 2005-06-06 SI SI200530415T patent/SI1768657T1/sl unknown
- 2005-06-06 JP JP2007518098A patent/JP4855396B2/ja not_active Expired - Fee Related
- 2005-06-06 SG SG200801546-3A patent/SG140607A1/en unknown
- 2005-06-06 BR BRPI0512569-3A patent/BRPI0512569A/pt not_active IP Right Cessation
- 2005-06-06 ES ES05758777T patent/ES2313368T3/es active Active
- 2005-06-06 NZ NZ551955A patent/NZ551955A/en not_active IP Right Cessation
- 2005-06-06 DE DE602005008970T patent/DE602005008970D1/de active Active
- 2005-06-06 AU AU2005262558A patent/AU2005262558B8/en not_active Ceased
- 2005-06-06 KR KR1020077001270A patent/KR100862930B1/ko not_active IP Right Cessation
- 2005-06-06 EP EP08014275A patent/EP2025336A1/en not_active Withdrawn
- 2005-06-06 CA CA2569691A patent/CA2569691C/en not_active Expired - Fee Related
- 2005-06-06 EP EP10181656A patent/EP2277516A1/en not_active Withdrawn
- 2005-06-10 US US11/150,641 patent/US8314152B2/en not_active Expired - Fee Related
- 2005-06-21 AR ARP050102545A patent/AR049929A1/es not_active Application Discontinuation
- 2005-06-22 TW TW094120880A patent/TWI396532B/zh not_active IP Right Cessation
-
2006
- 2006-12-06 IL IL179872A patent/IL179872A/en not_active IP Right Cessation
-
2007
- 2007-01-19 LV LVP-07-05A patent/LV13564B/lv unknown
- 2007-01-22 NO NO20070408A patent/NO20070408L/no not_active Application Discontinuation
- 2007-12-06 HK HK07113340.3A patent/HK1107671A1/xx not_active IP Right Cessation
-
2008
- 2008-11-12 CY CY20081101287T patent/CY1110435T1/el unknown
-
2010
- 2010-04-21 US US12/764,764 patent/US8410168B2/en not_active Expired - Fee Related
-
2011
- 2011-05-27 US US13/118,330 patent/US20110294891A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR049929A1 (es) | Metodos y composiciones para el tratamiento de afecciones oftalmicas con derivados de retinilo | |
AR055075A1 (es) | Metodos y composiciones para tratar trastornos oftalmicos mediante la modulacion del retinol en suero proteina enlazante de retinol en suero (rbp) y/o retinol rbp en suero | |
AR121843A2 (es) | Formulación oftálmica y método para mejorar la presbicia | |
DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
DOP2014000159A (es) | Composiciones enriquecidas con dpa de ácidos grasos omega 3 poliinsaturados en forma de ácido libre | |
MX2009011473A (es) | Regimenes de dosificacion para el tratamiento de enfermedades por almacenamiento lisosomal que utilizan chaperonas farmacologicas. | |
GT200600260A (es) | Derivados de benzamida y usos relacionados con los mismos | |
SV2011003901A (es) | Compuestos de arilo con sustituyentes heterocíclicos como inhibidores de hif | |
WO2007150046A3 (en) | Methods and compositions for treating ophthalmic conditions via modulation of megalin activity | |
CL2014001752A1 (es) | Compuestos biciclicos sustituidos; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades tales como cancer, alzheimer, sida, entre otras. | |
DOP2014000174A (es) | Composición y método para el diagnóstico y el tratamiento de las enfermedades asociadas a la degeneración de las neuritas | |
CR20130377A (es) | Métodos y productos de fármaco para tratar enfermedad de alzheimer | |
EA201590053A1 (ru) | Модуляторы пути системы комплемента и их применение | |
IN2012DN00352A (es) | ||
CU20140072A7 (es) | Derivados de dihidro-oxazina y dihidro-pirido-oxazina | |
AR090241A1 (es) | INHIBIDORES DE LA b-SECRETASA | |
CL2011003160A1 (es) | Compuestos derivados de heterociclicos, moduladores cb2; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades reumaticas, autoinmune, inflamatorias, dolor, entre otras. | |
CL2007000916A1 (es) | Uso de alcaftadina y de acido 6,11-dihidro-11-(1-metil-4-piperidiniliden)-5h-imidazo[2,1-b][3]benzazepin-3-carboxilico, sales, n-oxidos, solvatos e hidratos para tratar sintomas de alergia ocular, inflamacion ocular y sintomas nasales de alergia ocular; composiciones oftalmicas que los comprenden; su uso y kit farmaceutico. | |
GT201400222A (es) | Agentes para tratar trastornos que implican la modulación de receptores de rianodina | |
AR059555A1 (es) | Metodos para el tratamiento de degeneracion macular y condiciones oculares relacionadas | |
BR112014021602A2 (pt) | uso, kit e derivado de retinal sintético para melhorar a função visual em distúrbios visuais associados com a deficiência de produção endógena de retinóide | |
BR112016011527A2 (pt) | Derivados de imidazopiridina como moduladores de atividade de tnf | |
UY31243A1 (es) | Compuestos de 2-aza-biciclo[2.2.2]octano y usos para los mismos | |
ECSP11010956A (es) | Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos | |
PE20121700A1 (es) | Composicion que comprende l-carnitina o propionil l-carnitina, troxerutina, diosmina y hesperidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |